TC
Trium Capital Portfolio holdings
AUM
$163M
Turnover
55%
1-Year Est. Return
45.8%
This Fund
S&P 500
This Quarter
Est. Return
+22.3%
1 Year Est. Return
+45.8%
3 Year Est. Return
+188.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$402M
AUM Growth
-$399M
(-50%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
32.35%
Top 10 Holdings %
Top 10 Hldgs %
76.69%
Holding
80
New
25
Increased
14
Reduced
15
Closed
24
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.3
years
Top 20 Avg Time Held Equity + Options
0.3
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Canada ETF
EWC
|
+$67.1M |
| 2 |
SpringWorks Therapeutics
SWTX
|
+$35M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$26.3M |
| 4 |
Blueprint Medicines
BPMC
|
+$24.9M |
| 5 |
PlayAGS
AGS
|
+$22.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paragon 28, Inc.
FNA
|
+$36.5M |
| 2 |
Enfusion, Inc.
ENFN
|
+$19.4M |
| 3 |
Paycor HCM, Inc. Common Stock
PYCR
|
+$18.2M |
| 4 |
SolarWinds Corporation Common Stock
SWI
|
+$17.9M |
| 5 |
Intra-Cellular Therapies Inc.
ITCI
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.16% |
| 2 | Healthcare | 23.89% |
| 3 | Consumer Staples | 8% |
| 4 | Consumer Discretionary | 5.79% |
| 5 | Industrials | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
iShares MSCI Canada ETF
EWC
$7.15B
| $71.7M | 17.84% |
+1,552,508
| New | +$67.1M |
2025 Q2
0 quarters
|
|
|
2
DELISTED
SpringWorks Therapeutics
SWTX
| $37M | 9.21% |
+787,459
| New | +$35M |
2025 Q2
0 quarters
|
|
3
Albertsons Companies
ACI
$6.35B
| $32.1M | 8% |
1,494,308
+8,549
| +0.6% | +$186K |
2024 Q4
2 quarters
|
|
|
4
DELISTED
Blueprint Medicines
BPMC
| $30.8M | 7.66% |
+240,099
| New | +$24.9M |
2025 Q2
0 quarters
|
|
5
KraneShares CSI China Internet ETF
KWEB
$4.46B
| $30.2M | 7.51% |
879,504
+58,453
| +7% | +$1.94M |
2023 Q4
6 quarters
|
|
|
6
iShares MSCI Brazil ETF
EWZ
$11.9B
| $28.1M | 6.99% |
+973,211
| New | +$26.3M |
2025 Q2
0 quarters
|
|
7
iShares MSCI South Korea ETF
EWY
$22.8B
| $26.9M | 6.69% |
+374,732
| New | +$22.5M |
2025 Q2
0 quarters
|
|
|
8
DELISTED
PlayAGS
AGS
| $23.3M | 5.79% |
+1,864,241
| New | +$22.7M |
2025 Q2
0 quarters
|
|
9
DELISTED
Ansys
ANSS
| $14.6M | 3.62% |
+41,479
| New | +$13.6M |
2025 Q2
0 quarters
|
|
10
VanEck Vietnam ETF
VNM
$458M
| $13.6M | 3.38% |
989,128
+8,910
| +0.9% | +$113K |
2023 Q4
6 quarters
|
|
11
DELISTED
Inozyme Pharma
INZY
| $12.7M | 3.16% |
+3,173,454
| New | +$7.86M |
2025 Q2
0 quarters
|
|
12
iShares China Large-Cap ETF
FXI
$3.9B
| $8.49M | 2.11% |
230,950
+1,403
| +0.6% | +$49.1K |
2023 Q4
6 quarters
|
|
13
DELISTED
Redfin
RDFN
| $8.22M | 2.05% |
+734,608
| New | +$7.21M |
2025 Q2
0 quarters
|
|
14
iShares MSCI Mexico ETF
EWW
$1.43B
| $8.08M | 2.01% |
+133,373
| New | +$7.68M |
2025 Q2
0 quarters
|
|
15
Alumis Inc
ALMS
$784M
| $7.94M | 1.98% |
+2,648,039
| New | +$12.5M |
2025 Q2
0 quarters
|
|
16
DELISTED
ChampionX
CHX
| $7.85M | 1.95% |
+315,987
| New | +$7.96M |
2025 Q2
0 quarters
|
|
17
Quanterix
QTRX
$145M
| $3.9M | 0.97% |
586,425
+26,925
| +5% | +$150K |
2025 Q1
1 quarter
|
|
18
Equinox Gold
EQX
$12B
| $3.78M | 0.94% |
+655,897
| New | +$4.26M |
2025 Q2
0 quarters
|
|
19
DELISTED
NV5 Global
NVEE
| $3.76M | 0.93% |
+162,684
| New | +$3.26M |
2025 Q2
0 quarters
|
|
20
DELISTED
SatixFy Communications
SATX
| $2.37M | 0.59% |
+809,282
| New | +$1.96M |
2025 Q2
0 quarters
|
|
21
DELISTED
iCAD Inc
ICAD
| $2.13M | 0.53% |
+559,147
| New | +$1.87M |
2025 Q2
0 quarters
|
|
22
iShares MSCI Thailand ETF
THD
$424M
| $2.1M | 0.52% |
41,582
-611
| -1% | -$32.4K |
2023 Q4
6 quarters
|
|
23
Wabtec
WAB
$48.4B
| $1.76M | 0.44% |
8,402
-1,308
| -13% | -$252K |
2023 Q4
6 quarters
|
|
24
nVent Electric
NVT
$24.7B
| $1.42M | 0.35% |
19,391
+843
| +5% | +$51.8K |
2024 Q1
5 quarters
|
|
25
Owens Corning
OC
$8.79B
| $1.4M | 0.35% |
10,148
+66
| +0.7% | +$9.11K |
2023 Q1
9 quarters
|
|
Similar funds
VVM
GF
ACM
KFS
VB
RWA
CCM
CFG
Trium Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Trium Capital held 80 positions worth $402M, down 50% from $801M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Trium Capital deployed $130M of net new capital in Q2 2025, opening 25 new positions and adding to 14 existing holdings. Its largest new stake was iShares MSCI Canada ETF: 1,552,508 shares worth $71.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 76% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Trane Technologies, an estimated $808K trimmed.
- Trium Capital's largest Q2 2025 buy was iShares MSCI Canada ETF: 1,552,508 shares worth $71.7M.
- Trium Capital added most to KraneShares CSI China Internet ETF in Q2 2025, an estimated $1.94M increase.
- Trium Capital's biggest Q2 2025 reduction was Trane Technologies, cutting an estimated $808K.
- Trium Capital fully exited Paragon 28, Inc. in Q2 2025, selling an estimated $36.5M.
- Trium Capital's ten largest holdings make up 77% of its $402M portfolio in Q2 2025.
- Trium Capital opened 25 new positions and closed 24 in Q2 2025.
- Trium Capital's portfolio value fell 50% quarter-over-quarter to $402M.
Based on Trium Capital's 13F filing for Q2 2025, filed 11 Aug 2025.